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ABSTRACT
Combinations of selected phytochemicals (reserpine, pyrrolidine, quinine, morin and quercetin) 
with antibiotics (ciprofloxacin, tetracycline and erythromycin) were tested on the prevention and 
control of Staphylococcus aureus biofilms. The phytochemicals were also studied for their ability to 
avoid antibiotic adaptation and to inhibit antibiotic efflux pumps. Morin, pyrrolidine and quercetin 
at subinhibitory concentrations had significant effects in biofilm prevention and/or control when 
applied alone and combined with antibiotics. Synergism between antibiotics and phytochemicals 
was found especially against biofilms of NorA overexpressing strain S. aureus SA1199B. This strain 
when growing with subinhibitory concentrations of ciprofloxacin developed increased tolerance to 
this antibiotic. However, this was successfully reversed by quinine and morin. In addition, reserpine 
and quercetin showed significant efflux pump inhibition. The overall results demonstrate the role of 
phytochemicals in co-therapies to promote more efficient treatments and decrease antimicrobial 
resistance to antibiotics, with substantial effects against S. aureus in both planktonic and biofilm 
states.
Introduction
The widespread use of antibiotic-resistance elements 
among bacterial pathogens has made the treatment of 
some infections a serious concern. Indeed, many diseases 
that were once easily treatable have become deadly again 
(Brown & Wright 2016). It is clear from the past two dec-
ades of efforts that developing new, highly effective, safe 
and broad spectrum antibiotics has been an impossible 
task (IDSA 2011). New strategies are emerging to con-
trol microbial growth, including the use of combinations 
of therapeutic agents. The use of molecules antagonizing 
bacterial resistance mechanisms is a promising way to 
ensure the efficacy of antibiotics. Augmentin® (amoxi-
cillin-clavulanic acid), Timentin® (ticarcillin-clavulanic 
acid), Unasyn® (ampicillin-sulbactam) and Tazocin® (pip-
eracillin-tazobactam) are successful examples of com-
binatorial therapies effective against multidrug resistant 
strains (Abreu et al. 2013; Lewis 2013). More recently, com-
bined treatments between antibiotics and plant secondary 
metabolites showed promising results and represent an 
increasingly active research topic (Abreu et al. 2012, 2014, 
2015). Plant-based systems continue to play an essential 
role in healthcare, and their ethnopharmacological use 
has been extensively documented (Cragg & Newman 
2013). Numerous reports can be found on non-antimi-
crobial plant secondary metabolites that act as adjuvants 
in therapy, especially due to the inhibition of microbial 
resistance mechanisms, but also due to an overall improved 
solubility and stability of the active compounds (Gibbons 
et al. 2003; Mullin et al. 2004; Oluwatuyi et al. 2004; Abreu 
et al. 2012). In previous studies, three alkaloids – reserpine, 
pyrrolidine and quinine – and two flavonoids – morin and 
quercetin – at sub-inhibitory concentrations have shown 
to potentiate ciprofloxacin, tetracycline and erythromy-
cin against diverse antibiotic resistant strains of S. aureus 
in the planktonic state, including methicillin- resistant 
S. aureus (MRSA), presenting acceptable cytotoxicity 
(Abreu et al. 2014, 2015). Reserpine has been receiving 
much attention as an efflux pump inhibitor (EPI), despite 
some toxicity issues (Schmitz et al. 1998; Markham et al. 
1999; Gibbons & Udo 2000). However, to the authors’ 
knowledge, its effect was never tested against biofilms. 
Indeed, antimicrobial resistance is increased when micro-
organisms form biofilms (Olson et al. 2002; Burmolle 
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(at 10 g l−1) according to the manufacturer’s recommenda-
tions. Reserpine, pyrrolidine, quinine, morin and querce-
tin (Sigma) were prepared in dimethyl sulfoxide (DMSO; 
Sigma-Aldrich). Stock concentrations were prepared at 
10 g l−1 for quinine and reserpine and 50 g l−1 for morin, 
quercetin and pyrroldine. The compounds were stored 
at –4°C.
Biofilm formation, prevention and control
The minimal inhibitory concentration (MIC) of the anti-
biotics and phytochemicals were first determined against 
planktonic cells according to CLSI guidelines (CLSI 2003) 
and as described by Abreu et al. (2014, 2015). Antibiotics 
were applied at MIC, 10 × MIC and 50 × MIC against 
biofilms. The phytochemicals were found to have no 
antimicrobial activity for the concentrations tested (up 
to 1,500 mg l−1, data not shown). Consequently, the con-
centrations applied corresponded to the optimal concen-
trations previously found to potentiate the antibiotics 
against the tested bacteria in planktonic state: 100 mg l−1 
for reserpine and quinine and 500 mg l−1 for pyrrolidine, 
quercetin and morin (Abreu et al. 2014, 2015).
Antibiotics and phytochemicals were tested individu-
ally and in combination in order to assess their ability to 
control biofilms and prevent their formation. Overnight 
cultures adjusted to a cell density of 106 cells ml−1 were 
added to sterile 96-well polystyrene microtiter plates 
(Orange Scientific, Braine-l'Alleud, Belgium) to form 
biofilms during 24 h at 37°C and 150 rpm. Afterwards, 
the medium was removed and the biofilms were exposed 
to the antibiotics, phytochemicals and their combinations 
(at 5% (v v–1) of the well for a final volume of 200 μ l−1), 
for 1 h at 37°C and 150 rpm. The same protocol was per-
formed for an exposure time of 24 h. These assays tested 
the effects of two exposure times in the control of estab-
lished biofilms.
In order to assess the combinations towards the preven-
tion of biofilm formation, overnight cell suspensions were 
added to microtiter plates along with antibiotics, phyto-
chemicals and their combinations (5% v v–1 of the well). 
The plates were incubated for 24 h at 37°C and 150 rpm. 
After incubation, biofilms were scraped and diluted in 
saline solution (0.85% NaCl). The numbers of colony 
forming units per unit of adhesion area (CFU  cm−2) 
were assessed in MH agar for both biofilm control and 
prevention experiments. The results are presented as a 
log10 CFU cm−2 reduction from the DMSO control.
A phytochemical-antibiotic synergy assay was per-
formed according to Monzon et al. (2001). The combi-
nation was considered synergic when the log10 reduction 
CFU  cm−2 caused by a combination was significantly 
higher (p  <  0.05) than the sum of reductions by the 
et al. 2006; Verstraeten et al. 2008). It is estimated 
that > 80% of bacterial infections in humans involve the 
formation of biofilms (Brooun et al. 2000; Simoes et al. 
2008; Busetti et al. 2010). Moreover, antimicrobial studies 
using planktonic cells despite having provided extensive 
information describing the mechanisms inhibiting bacte-
rial growth may not be enough to predict therapeutic suc-
cess (Pratt & Kolter 1998). In this work, combinations of 
phytochemicals and antibiotics were evaluated with respect 
to the prevention and control of Staphylococcus aureus 
biofilms. It may be expected that by combining antibiotics 
with an adjuvant, acting as biofilm inhibitor, as resistance- 
modifying agent, or even as a cell permeabilizer, the out-
come would be an improved therapeutic benefit (Abreu 
et al. 2013). Further experiments were performed in order 
to understand the mode of action of these phytochemicals 
and whether the synergic combinations of phytochemicals 
and antibiotics were due to resistance modifying activity.
Materials and methods
Bacteria and culture conditions
S. aureus SA1199B, S. aureus RN4220 and S. aureus 
XU212, which overexpress the NorA, TetK and MsrA 
efflux pumps, respectively, were kindly provided by 
S. Gibbons (University College London, UCL) (Gibbons 
& Udo 2000; Gibbons et al. 2003; Oluwatuyi et al. 2004; 
Smith et al. 2007). The collection strain S. aureus CECT 
976 was included as a quality control strain. The strains 
were stored at –80°C. Prior use, they were transferred to 
a Mueller–Hinton (MH, Merck Millipore, Germany) agar 
plate grown overnight and inoculated in MH broth at 37°C 
and under agitation (150 rpm). Bacterial susceptibility was 
assessed following the Clinical and Laboratory Standards 
Institute (CLSI 2003) guidelines as shown in Table 1.
Preparation of antibiotics and phytochemicals
Stock solutions of ciprofloxacin, erythromycin and 
 tetracycline (Sigma, Sintra, Portugal) were prepared 
Table 1. Characteristics of the S. aureus strains.
notes: MiC were determined for each strain according to ClSi guidelines (ClSi 
2003) and classified as resistant (R) or susceptible (S) to ciprofloxacin (CiP), 
tetracycline (TET) and erythromycin (ERY).
Strains Antibiotic MIC (mg l−1) Description
CECT 976 CiP 1 (S) from the Spanish Type Culture 
Collection; no antibiotic 
resistance described
TET 0.96 (S)
ERY 0.24 (S)
SA1199B CiP 128 (R) overexpresses norA efflux 
pump
Xu212 TET 128 (R) overexpresses the TetK efflux 
pump
Rn4220 ERY 256 (R) Contains plasmid pu5054 (that 
carries the gene encoding the 
MsrA efflux protein)
BIofouLINg  1105
individual treatments. An antagonistic combination was 
characterized when the log10 reduction in CFU cm‒2 of the 
combination was significantly lower (p < 0.05) than that 
obtained with the more active product.
Antibiotic adaptation assay
An antibiotic adaptation assay was performed with 
S. aureus SA1199B growing with increasing subinhibitory 
concentrations of ciprofloxacin for 15 days, according to 
Figure 1. The most promising phytochemical-antibiotic 
synergy results were obtained with this strain, and there-
fore it was selected for the antibiotic adaptation assay 
aiming to understand whether the phytochemicals were 
effective in reversing bacterial resistance or avoiding the 
development of resistance due to prolonged exposure. 
S. aureus SA1199B was grown overnight in MH broth 
at 37°C, adjusted to a cell density of 106 cells ml−1 and 
incubated with ciprofloxacin at 1/32  ×  MIC (4  mg  l−1, 
phase 1) for 24 h (at 37°C and 150 rpm agitation) in the 
presence of each phytochemical. After 24 h, the bacterium 
was refreshed: centrifugation was performed at 3,999 g for 
10 min, the supernatant discarded, the pellet was washed 
twice and resuspended in MH broth with both mole-
cules (at the same concentrations). This procedure was 
repeated after 48 h. On the fourth day, after washing the 
cultures, the concentration of the antibiotic was increased 
to 1/16 × MIC (8 mg l−1, phase 2), and consecutively, for a 
total of 15 days, until a final concentration of 1/2 × MIC 
was reached. Controls were performed in the absence of 
phytochemicals or ciprofloxacin and with DMSO (5% 
v  v–1). Bacterial samples were taken every three  days, 
washed as previously described and susceptibility profiles 
of bacterial populations to ciprofloxacin were evaluated by 
the disk diffusion method according to CLSI guidelines 
(CLSI 2003). The final population grown in the presence 
of only ciprofloxacin (named SA1199B(r)) was recovered 
after 15 days, washed and stocks were prepared for further 
experiments to assess efflux pump inhibition with ethid-
ium bromide (EtBr). Triplicates of each combination were 
performed.
Disk diffusion method
Bacterial suspensions were adjusted to 0.5 McFarland 
standards and seeded over hardened MH agar in Petri 
dishes using a sterilized cotton swab. Sterile blank disks 
(6  mm diameter; Oxoid, Madrid, Spain) were placed 
on the agar plate seeded with the respective bacteria. A 
volume of 10 μl of ciprofloxacin prepared according to 
CLSI (2003) (ciprofloxacin –5 μg disk−1) was added to the 
blank disks. Disks with 10 μl of DMSO were used as neg-
ative control. The plates were incubated at 37°C for 24 h. 
After incubation each inhibition zone diameter (IZD) 
was recorded and antibiotic susceptibility was analyzed 
according to CLSI guidelines (CLSI 2003). No inhibition 
zone was obtained with DMSO (data not shown). All tests 
were performed in triplicate.
Ethidium bromide accumulation assay
Ethidium bromide (EtBr) accumulation was tested in order 
to assess the putative action of phytochemicals as NorA 
inhibitors. First, the MIC of EtBr (prepared in a stock of 
10 g l−1) was first determined according to CLSI guidelines 
(CLSI 2003) and described by Abreu et al. (2014, 2015). 
The detection of EtBr accumulation by S. aureus strains 
was performed using a fluorometric method according 
to Rodrigues et al. (2013) and Jin et al. (2011). Briefly, 
bacteria were grown in MH broth at 37°C until mid-log 
phase (OD600 of 0.6 to 0.7). Bacterial suspensions were 
centrifuged at 3,999  g for 10  min, the supernatant was 
discarded, the pellet was washed in phosphate buffered 
saline (PBS; pH 7.4), and bacterial suspension adjusted 
to 108 CFU ml−1 with PBS. Aliquots of 100 μl of the bac-
terial suspensions were transferred to wells of a 96-well 
plate containing serial dilutions of EtBr at concentrations 
ranging from 80 to 0.06 mg l−1. In order to assess the effect 
of phytochemicals on EtBr accumulation, EtBr (at ½ MIC, 
in order not to compromise the bacterial viability) was 
applied in the absence or presence of each phytochemical: 
reserpine and quinine at 100 mg l−1; pyrrolidine, quercetin 
and morin at 500 mg l−1 (Abreu et al. 2014, 2015). The neg-
ative control was performed with 5% (v v–1) DMSO. Also, 
controls for each phytochemical with EtBr in PBS were 
performed in order to detect possible fluorescence emitted 
by the products themselves. Fluorescence was acquired 
every 1 min for 60 min at 37°C in a microplate reader 
(Spectramax M2e, Molecular Devices, Inc., Sunnyvale, 
CA, USA) using 530 and 590 nm as excitation and detec-
tion wavelengths, respectively.
Figure 1. Scheme of ciprofloxacin treatment applied to S. aureus 
SA1199B for 15  days in order to assess bacterial adaptation. 
Bacterial cultures were incubated with defined subinhibitory 
concentrations of ciprofloxacin increasing every three  days 
(from 1/32  ×  MiC to 1/2  ×  MiC) for a total of 15  days. Bacterial 
susceptibility to ciprofloxacin was determined in the end of each 
cycle by disk diffusion method (ClSi 2003).
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biofilms expresses a different set of genes such as ica types, 
and  bap and  agr  types, with an increased potential to 
induce the development of recurrent infections (Gogoi-
Tiwari et al. 2015). Therefore, new biofilm control strat-
egies are required. Phytochemicals have been extensively 
studied as antibacterial products and, more recently, as 
potentiators/adjuvants of antibiotics (Markham et al. 
1999; Abreu et al. 2012). However, few data can be found 
on their effects against biofilms, even though most infec-
tions are biofilm-related. The ability of phytochemicals 
and antibiotics to control 24 h old biofilms formed in ster-
ile 96-well polystyrene microtiter plates within 1 and 24 h 
of exposure was evaluated. Antibiotics were first applied 
alone at MIC, 10 × MIC and 50 × MIC. As no significant 
differences (p > 0.05) in biofilm log10 CFU cm−2 reduction 
were obtained (data not shown), the combinations were 
Statistical analysis
The results were analyzed by Student’s t-test using SPSS 
(Statistical Package for the Social Sciences) version 19.0 
(IBM Corp., Armonk, NY, USA). Statistical calculations 
were based on a confidence level 95% (p < 0.05) which was 
considered statistically significant. All p-values reported 
were two-tailed.
Results and discussion
Biofilms are recognized for their insusceptibility to cur-
rent therapeutic approaches (Smith 2005; Römling & 
Balsalobre 2012). This is due to the different character-
istics of biofilm cells compared to their planktonic coun-
terparts (Simões et al. 2009). For instance, S. aureus  in 
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Figure 2. Cfu cm−2 of biofilms after exposure to antibiotics and phytochemicals for 1 h: S. aureus CECT976 (A), SA1199B (B), Xu212 (C) 
and Rn4220 (D). Strains SA1199B, Xu212 and Rn4220 were only exposed to the antibiotics to which they are resistant: CiP, TET and ERY, 
respectively. Antibiotics were applied at MiC; reserpine and quinine were applied at 100 mg l−1; pyrrolidine, morin and quercetin were 
applied at 500 mg l−1. a, when statistically lower than gC (p < 0.05); b, when statistically lower than gC and the antibiotics (p < 0.05). gC, 
growth control (5%, v v–1 DMSo); CiP, ciprofloxacin; TET, tetracycline; ERY, erythromycin.
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morin and pyrrolidine were not effective (p  <  0.05) in 
disturbing biofilms for a 24 h exposure period, for which 
the maximal log10 CFU cm−2 reductions were 0.3 and 0.5, 
respectively (Figure 3). The decreased susceptibility to 
prolonged exposure periods was generally observed for 
almost all the strains. This is probably due to the effects of 
longer incubation periods. The fast growing cells will die 
readily when exposed to the antibiotics but the dormant 
cells fraction can survive and replicate (Shafahi & Vafai 
2010). The exception was verified with strain SA1199B 
when exposed to ciprofloxacin, where the log10 CFU cm−2 
reduction increased with the longer exposure from 0.4 
to 1.1.
Additionally, in order to assess the ability of the 
 phytochemicals to prevent bacterial adhesion and biofilm 
performed with antibiotics at their MIC. Figures 2 and 3 
present the number of CFU cm−2 in the biofilm after incu-
bation with antibiotics at their MIC and phytochemicals 
individually for 1 and 24 h, respectively. Phytochemicals 
were applied at subinhibitory concentrations that were pre-
viously found to cause antibiotic-potentiation (Abreu et al. 
2014, 2015). Morin at 500 mg l−1 applied for 1 h (Figure 2) 
caused the highest CFU reductions (log10 CFU cm−2 reduc-
tions of 1.2 - 2.1 for all strains), followed by pyrrolidine (at 
500 mg l−1, log10 CFU cm−2 reductions of 0.7 - 1.1). These 
reductions were higher (p  <  0.05) than those obtained 
with antibiotics applied at MIC (log10 CFU cm−2 reduc-
tions of 0.08–0.4). These results proposed that the selected 
phytochemicals caused biofilm disruption as they did 
not show antimicrobial activity by themselves. However, 
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Figure 3. Cfu cm−2 of biofilms after exposure to antibiotics and phytochemicals for 24 h. S. aureus CECT976 (A), SA1199B (B), Xu212 (C) 
and Rn4220 (D). Strains SA1199B, Xu212 and Rn4220 were only exposed to the antibiotics to which they are resistant: CiP, TET and ERY, 
respectively. Antibiotics were applied at MiC; reserpine and quinine were applied at 100 mg l−1; pyrrolidine, morin and quercetin were 
applied at 500 mg l−1. a, when statistically lower than gC (p < 0.05); b, when statistically lower than gC and the antibiotics (p < 0.05). gC, 
growth control (5%, v v–1 DMSo); CiP, ciprofloxacin; TET, tetracycline; ERY, erythromycin.
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biofilm control or prevention. This reinforces the higher 
tolerance of biofilm cells compared to their planktonic 
counterparts. Studies report that even cells that are 
merely adhered to a surface have more resistant pheno-
types (Bridier et al. 2011). However, it seems that among 
all the phytochemicals, morin was particularly effective 
in controlling (within 1 h of incubation) and inhibiting 
biofilm formation. Morin can therefore be added to the 
reduced list of phytochemicals with potential to interfere 
with the process of biofilm formation and development 
(Simões et al. 2009).
Table 2 presents the log10 CFU cm−2 reductions caused 
by the phytochemical–antibiotic combinations applied to 
all strains. The maximum CFU reduction was obtained 
after 24 h exposure to the synergic combination of cip-
rofloxacin and quinine (2.1 log10 CFU cm−2 reduction) 
against SA1199B biofilms. Additionally, a combination of 
formation, tests with sessile cells were performed in the 
presence of the phytochemicals for 24  h. Figure 4 pre-
sents the number of CFU cm−2 that was able to adhere 
to polystyrene when grown in the presence of the anti-
biotics and phytochemicals for 24  h. All antibiotics (at 
MIC) caused significant prevention of biofilm formation 
– a reduced number of CFU cm−2 compared to growth 
control (p  <  0.05). Morin was able to reduce biofilm 
formation of all strains (p < 0.05), especially of RN4220 
(1.4 log10 CFU cm−2 reduction). Additionally, quercetin 
at 500 mg l−1 also had a considerable effect in prevent-
ing biofilm formation (p < 0.05), particularly of strains 
SA1199B and XU212 (~1 log10  CFU  cm−2 reduction). 
Pyrrolidine was unable to prevent biofilm formation, as 
it did not affect biofilm removal when applied for 24 h, 
despite showing significant effects when applied for 1 h 
(p < 0.05). No antibiotic or phytochemical caused total 
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Figure 4. Cfu cm−2 of S. aureus CECT976 (A), SA1199B (B), Xu212 (C) and Rn4220 (D) biofilms after 24 h growth in the presence of 
antibiotics and phytochemicals. Strains SA1199B, Xu212 and Rn4220 strains were only exposed to the antibiotics to which they are 
resistant to: CiP, TET and ERY, respectively. Antibiotics were applied at MiC; reserpine and quinine were applied at 100 mg l−1; pyrrolidine, 
morin and quercetin were applied at 500 mg l−1. a, when statistically lower than gC (p < 0.05); b, when statistically lower than gC and the 
antibiotics (p < 0.05). gC, growth control (5%, v v–1 DMSo); CiP, ciprofloxacin; TET, tetracycline; ERY, erythromycin.
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responses. The remaining combinations tested had indif-
ferent effects on biofilm prevention and control.
Since most synergic interactions were obtained 
against strain SA1199B (a NorA overexpressing strain), 
a further experiment was conducted to induce adapta-
tion of SA1199B to ciprofloxacin. The phytochemicals 
were also used to understand their effects in reversing 
bacterial adaptation to ciprofloxacin after long exposure 
times. Figure 5 shows the results obtained in the adapta-
tion assay with SA1199B to ciprofloxacin (the treatment 
was performed as previously indicated in Figure 1). By 
growing this strain with subinhibitory concentrations of 
ciprofloxacin (control assay) it was possible to observe a 
reduction in the IZD until day 9 (phase 3), and then no 
IZD was detected (phases 4 and 5), indicating that bac-
teria became more resistant to ciprofloxacin. Biological 
responses induced in bacteria when antibiotics are applied 
at subinhibitory concentrations can affect various cellu-
lar responses or alter gene expression leading to differ-
ent adaptive responses impacting antibiotic resistance/
tolerance (Kaplan et al. 2012; Bernier & Surette 2013). A 
potential increased NorA overexpression could explain 
the improved tolerance to ciprofloxacin observed by strain 
SA1199B. In phases 2 and 3, it was possible to observe 
that the populations growing in the presence of all phy-
tochemicals were more susceptible, since IZD promoted 
by ciprofloxacin were significantly higher (p < 0.05) than 
IZD obtained when bacteria were growing only in the 
presence of ciprofloxacin. According to CLSI guidelines 
(CLSI 2003) IZD obtained in phase 3 allows characteriza-
tion of the bacterial cultures as susceptible to ciprofloxa-
cin. This susceptibility was observed earlier for quercetin 
growing-population (in phase 1). This means that until 
day 9, all the phytochemicals were able to reverse the 
bacterial resistance mechanisms. However, by increasing 
ciprofloxacin concentrations to ¼ and ½ MIC (phases 
4 and 5, respectively), all populations were resistant to 
ciprofloxacin with reserpine, also considered synergic, was 
the most efficient in preventing biofilm formation (a 3.5 
log10 CFU cm−2 reduction) of strain SA1199B. Other syn-
ergic antibiotic–phytochemical combinations were found, 
with the following causing ≥ 1 log10 CFU cm−2 reduction: 
ciprofloxacin combined with pyrrolidine and reserpine 
(a log10 CFU cm−2 reduction of 1.7 and 1.3, respectively) 
to control SA1199B biofilms exposed for 24 h; erythro-
mycin combined with pyrrolidine to control biofilms of 
CECT976 exposed for 1 h (a 1.4 log10 CFU cm−2 reduction) 
and also to prevent their formation (a 2.1 log10 CFU cm−2 
reduction); and tetracycline combined with pyrrolidine 
and morin to prevent biofilm formation of XU212 (a 
log10 CFU cm−2 reduction of 1.6 and 1.1, respectively). 
The majority of these synergic results corroborate previ-
ous studies with planktonic cells (Abreu et al. 2014, 2015). 
Some antagonistic results were obtained, especially for 
combinations involving the phenolic compounds. It seems 
that the presence of antibiotics disturbs the activity of 
morin, which was found to be effective when applied indi-
vidually for 1 h. Indeed, biofilms facilitate the spread of 
antibiotic resistance by promoting horizontal gene trans-
fer and cells can switch to more tolerant phenotypes upon 
environmental stress (Fux et al. 2005). Antagonistic com-
binations were also found with quercetin when combined 
with antibiotics mainly against CECT976 biofilms. Other 
discrepancies in the effects against the diverse strains were 
found, such as the fact that combinations of tetracycline 
with morin and tetracycline with pyrrolidine were syner-
gic against XU212 but antagonistic against CECT976 in 
a biofilm control for 24 h and biofilm prevention, respec-
tively. This strain-dependent susceptibility can be related 
to the impact of combined stresses on their susceptibility/
resistance patterns and it would need a more integrated 
approach in order to be fully understood. Antibiotic-
mediated interactions may trigger multicellular behav-
ior in bacteria, which makes it impossible to predict cell 
Table 2. log10 Cfu cm
−2 reductions after biofilm exposure to antibiotic-phytochemical combinations.
A – biofilm exposure to antibiotics and phytochemicals for 1 h; B – biofilm exposure to antibiotics and phytochemicals for 24 h; C – biofilm grown in the presence 
of antibiotics and phytochemical/biofilm prevention. The combination was considered synergic (S) when a log10 Cfu cm
−2 reduction by the combination was 
significantly higher (p < 0.05) than the sum of log10 Cfu cm
−2 reductions in individual treatments (Monzon et al. 2001). An antagonistic (A) combination was 
obtained when the log10 Cfu cm
−2 reduction in the combination was significantly lower (p < 0.05) than that obtained with the most effective product. Bold 
values represent synergic interactions with a log10 Cfu cm
−2 reduction ≥ 1.0.
*Pyr, Mor, Querc: 500 mg l−1; Res, Quin: 100 mg l−1. CiP, ciprofloxacin; TET, tetracycline; ERY, erythromycin; Res, reserpine; Pyr, pyrrolidine; Quin, quinine, Mor, morin; 
Querc, quercetin.
Log10 Cfu cm
−2 reductions
Strains Antib.
A - Biofilm control (1 h) B - Biofilm control (24 h) C - Biofilm prevention
res Pyr Qui Mor Querc res Pyr Qui Mor Querc res Pyr Qui Mor Querc
CECT 976 CiP 0.29 0.91 0.36 1.29 0.45 0.33 0.52 0.48 0.05 (A) 0.03 (A) 3.21 3.34 3.51 1.42 (A) 1.13 (A)
TET 0.49 0.81 0.42 0.99 0.05 (A) 0.28 0.24 (A) 0.25 0.04 (A) 0.04 (A) 1.43 0.97 (A) 1.41 1.33 1.06 (A)
ERY 0.28 1.44 (S) 0.26 0.64 (A) 0.28 0.49 0.47 0.48 0.18 0.28 (A) 1.51 2.09 (S) 1.50 1.17 1.18
SA1199B CiP 0.37 1.10 0.53 0.98 (A) 0.57 1.30 (S) 1.71 (S) 2.10 (S) 1.05 0.92 3.52 (S) 2.7 3.05 3.43 2.11
Xu212 TET 0.33 0.93 0.29 0.92 (A) 0.37 0.23 0.16 0.22 0.33 (S) 0.11 0.70(S) 1.55 (S) 0.48 1.12 (S) 1.16
Rn4220 ERY 0.01 1.08 0.24 (S) 1.03 (A) 0.47 (S) 0.36 0.39 0.49 0.29 0.05 (A) 1.08 1.03 1.07 1.26 0.84
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significant differences between accumulation by SA1199B 
and SA1199B(r) (p > 0.05), suggesting that the higher resist-
ance of this strain to ciprofloxacin may be due to the expres-
sion of resistance mechanisms other than overexpression of 
NorA efflux pump. Figure 6B shows the effect of several con-
centrations of reserpine on EtBr accumulation. Reserpine at 
20 mg l−1 is usually used as reference (Schmitz et al. 1998; 
Couto et al. 2008). Figure 6C shows the accumulation of 
EtBr by SA1199B in the presence of the phytochemicals. 
Quercetin (at 500  mg  l−1) showed the best accumulation 
results (p < 0.05). Quinine (at 100 mg  l−1) also improved 
EtBr accumulation (p < 0.05), suggesting that this compound 
inhibited the NorA efflux pump, apparently inducing higher 
tolerance of SA1199B to ciprofloxacin. Morin (at 500 mg l−1) 
had no effect on EtBr accumulation, but it was able to pre-
vent bacterial adaptation to ciprofloxacin, suggesting that 
this product is apparently involved in the inhibition of other 
mechanism, excluding the NorA efflux pump. Interestingly, 
the difference in the structures between morin and quercetin 
is that the first is 2′,4′-dihydroxylated in B ring while the 
second is 3′,4′-dyhydroxylated. However, it is already known 
that different substitutions on phenolic rings can promote 
significantly different activities (Cushnie & Lamb 2005; 
Kumar & Pandey 2013). Indeed, Tsuchiya et al. (1996) indi-
cated that 2′,4′- or 2′,6′-dihydroxylation of the B ring and 
5,7-dihydroxylation of the A ring in the flavanone structure 
was important for anti-MRSA activity. Previous findings 
using flavonols, such as fisetin, quercetin, and kaempferol 
described their anti-biofilm activity against S. aureus (Lee 
et al. 2013). In addition, it was found previously that several 
ciprofloxacin similar to the control (no IZD detected), 
with the exception of bacteria growing in the presence of 
quinine and morin. The results indicate that both phy-
tochemicals were successful in preventing tolerance to 
ciprofloxacin by strain SA1199B (p < 0.05).
The potential of the phytochemicals to inhibit NorA was 
tested using EtBr, a substrate widely applied for detecting 
efflux activity in S. aureus strains (Costa et al. 2013). EtBr 
form complexes with double stranded DNA and RNA by 
intercalating between base pairs (Walberg et al. 1999). Several 
products, such as reserpine, behave as if they inhibit efflux 
pumps and hence have become known EPI (Holler et al. 
2012). Accumulation of EtBr inside the bacterial cells can 
be increased in the presence of an EPI (Mullin et al. 2004; 
Holler et al. 2012) and can be measured fluorometrically in 
SA1199B cells due to the retention of fluorescence over time. 
Also, in order to understand if overexpression of NorA is the 
reason for the increased tolerance of bacterial cells grow-
ing with ciprofloxacin for 15 days, this population, named 
SA1199B(r), was included in the experiments. The suscepti-
ble strain CECT976 was also tested as negative control. The 
MIC of EtBr was first determined for each strain: 5 mg l−1 
for CECT976 and 40 mg l−1 for SA1199B and SA1199B(r). 
Due to the good sensitivity of the fluorometric method, 
the demonstration of the effects of reserpine on the accu-
mulation of EtBr on strain SA1199B over time was readily 
made. Figure 6A shows the comparison between EtBr accu-
mulation in strains CECT976, SA1199B and SA1199B(r). 
CECT976 accumulated more EtBr contrarily to SA1199B 
and SA1199B(r), both overexpressing NorA. There were no 
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Figure 5.  inhibition zone diameter (iZD) promoted by ciprofloxacin against S. aureus SA1199B grown in the presence of increasing 
subinhibitory concentrations of ciprofloxacin (CiP) alone and in the presence of phytochemicals. Reserpine and quinine were applied 
at 100 mg l−1; pyrrolidine, morin and quercetin at 500 mg l−1. Results are given for the five different phases of this assay by increasing 
ciprofloxacin concentrations every three days (from 1/32 MiC to 1/2 MiC) over a total of 15 days, according to figure 1. Bars with (*) 
presented significantly higher inhibition zone diameters (p < 0.05) compared to the ciprofloxacin control population, for each phase.
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of cells, are shared between clinical and environmental 
bacteria (Wright 2010). Therefore, products that inter-
fere with efflux of active inhibitors from the cell or other 
resistance mechanisms may be easily found in nature. 
Studies on plants allowed the discovery of interesting 
efflux pump inhibitors. This is an attractive strategy for the 
design of novel therapeutic approaches. With this study, 
known phytochemicals are highlighted for their important 
activities in co-therapies with known antibiotics against 
S. aureus biofilms.
In conclusion, despite being structurally different 
and presenting diverse activities, all the phytochemicals 
flavonoids, particularly quercetin, reduced hemolysis by   
S. aureus which would reduce its virulence and ability to 
form biofilms (Caiazza & O’Toole 2003). Pyrrolidine did 
not improve EtBr accumulation neither was able to avoid or 
increase resistant of SA1199B strain (p > 0.05). However, it 
caused biofilm removal when applied for 1 h.
Over the last decade there has been a resurgence of 
interest in the search for products that will restore the 
activity of licensed antimicrobial agents (Abreu et al. 
2012). The prospects of finding useful plant-derived 
products are enormous. Many resistant mechanisms to 
antimicrobials, such as the ability to pump antibiotics out 
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Figure 6. fluorescence as a measure of EtBr accumulation. (A) EtBr accumulation in S. aureus CECT976, SA1199B and SA1199B(r); (B) 
effects of reserpine at 20, 40 and 100  mg  l−1 on EtBr accumulation; (C) effects of phytochemicals on EtBr accumulation in S. aureus 
SA1199B. The bacteria were loaded with EtBr at ½ MiC in the presence of different phytochemicals for a period of 1 h at 37°C. Mean values 
of three replicates are shown.
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